NFGC Q1 2026 Earnings Deep EPS Miss Underscores PreRevenue Stage Challenges Veracyte VCYT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Rigel Pharmaceuticals Q1 2026 Earnings EPS Falls Short of Expectations MYGN Q1 2026 Earnings EPS Misses Estimates as Strategic Investments Weigh on Results Lesaka Technologies Q1 2026 Earnings EPS Surges Past Estimates with 978 Surprise